Result of subscription rights exercise.


    02 May 2025 22:56:02
  • Source: Sharecast
RNS Number : 2222H
Geiger Counter Ltd
02 May 2025
 

 

2 May 2025

GEIGER COUNTER LIMITED
(THE "COMPANY")

 

Result of subscription rights exercise for Ordinary Shares

The Board of the Company announces that applications have been received from shareholders to subscribe for 101,658 new ordinary shares of no par value ("Ordinary Shares") at a price of 74.58 pence per share (the "Subscription Price"). 

The Board have determined however, that due to the Ordinary Share price (being materially lower than the Subscription Price both currently and during the run up to the close of the Subscription Rights exercise, it would not be in the best interests of the Company to issue new shares at this level. As a reference the Ordinary Shares have traded between 28 pence and 36 pence since the beginning of April 2025.

Accordingly, the Company announces that no new Ordinary Shares will be issued as a result of the subscription rights exercise for 2025 and that applicants will be refunded by the Registrar as soon as possible.

For further information, please contact:

Enquiries

Manulife | CQS

Craig Cleland

T: +44 (0) 20 7201 5368

 

Cavendish Capital Markets Limited

Tunga Chigovanyika (Corporate Finance)

 

T: +44 (0) 20 7397 1915

 



Daniel Balabanoff / Pauline Tribe (Sales)

 

T: +44 (0) 20 7220 0517

R&H Fund Services (Jersey) Limited

Jane De Barros

T :+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIGZGGKVZFGKZG

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.